896 related articles for article (PubMed ID: 30530866)
41. Cutting-edge apoptosis-based therapeutics: a panacea for cancer?
Fischer U; Janssen K; Schulze-Osthoff K
BioDrugs; 2007; 21(5):273-97. PubMed ID: 17896835
[TBL] [Abstract][Full Text] [Related]
42. Bypassing cancer drug resistance by activating multiple death pathways--a proposal from the study of circumventing cancer drug resistance by induction of necroptosis.
Hu X; Xuan Y
Cancer Lett; 2008 Feb; 259(2):127-37. PubMed ID: 18082322
[TBL] [Abstract][Full Text] [Related]
43. Grape seed extract induces apoptotic death of human prostate carcinoma DU145 cells via caspases activation accompanied by dissipation of mitochondrial membrane potential and cytochrome c release.
Agarwal C; Singh RP; Agarwal R
Carcinogenesis; 2002 Nov; 23(11):1869-76. PubMed ID: 12419835
[TBL] [Abstract][Full Text] [Related]
44. Inhibitors of apoptosis: clinical implications in cancer.
Mohamed MS; Bishr MK; Almutairi FM; Ali AG
Apoptosis; 2017 Dec; 22(12):1487-1509. PubMed ID: 29067538
[TBL] [Abstract][Full Text] [Related]
45. Stroke, myocardial infarction, acute and chronic inflammatory diseases: caspases and other apoptotic molecules as targets for drug development.
Kreuter M; Langer C; Kerkhoff C; Reddanna P; Kania AL; Maddika S; Chlichlia K; Bui TN; Los M
Arch Immunol Ther Exp (Warsz); 2004; 52(3):141-55. PubMed ID: 15247881
[TBL] [Abstract][Full Text] [Related]
46. Caspase-independent apoptosis in yeast.
Liang Q; Li W; Zhou B
Biochim Biophys Acta; 2008 Jul; 1783(7):1311-9. PubMed ID: 18358844
[TBL] [Abstract][Full Text] [Related]
47. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.
Tamm I; Wang Y; Sausville E; Scudiero DA; Vigna N; Oltersdorf T; Reed JC
Cancer Res; 1998 Dec; 58(23):5315-20. PubMed ID: 9850056
[TBL] [Abstract][Full Text] [Related]
48. E3 ubiquitin ligases and deubiquitinases as modulators of TRAIL-mediated extrinsic apoptotic signaling pathway.
Woo SM; Kwon TK
BMB Rep; 2019 Feb; 52(2):119-126. PubMed ID: 30638181
[TBL] [Abstract][Full Text] [Related]
49. Modulation of apoptosis signaling for cancer therapy.
Fulda S; Debatin KM
Arch Immunol Ther Exp (Warsz); 2006; 54(3):173-5. PubMed ID: 16652217
[TBL] [Abstract][Full Text] [Related]
50. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy.
Yang L; Cao Z; Yan H; Wood WC
Cancer Res; 2003 Oct; 63(20):6815-24. PubMed ID: 14583479
[TBL] [Abstract][Full Text] [Related]
51. Apoptosis: mechanisms and relevance in cancer.
Vermeulen K; Van Bockstaele DR; Berneman ZN
Ann Hematol; 2005 Oct; 84(10):627-39. PubMed ID: 16041532
[TBL] [Abstract][Full Text] [Related]
52. Is cisplatin-induced cell death always produced by apoptosis?
Gonzalez VM; Fuertes MA; Alonso C; Perez JM
Mol Pharmacol; 2001 Apr; 59(4):657-63. PubMed ID: 11259608
[TBL] [Abstract][Full Text] [Related]
53. Reversine induces caspase-dependent apoptosis of human osteosarcoma cells through extrinsic and intrinsic apoptotic signaling pathways.
Kim JS; Cho IA; Kang KR; Lim H; Kim TH; Yu SK; Kim HJ; Lee SA; Moon SM; Chun HS; Kim CS; Kim DK
Genes Genomics; 2019 Jun; 41(6):657-665. PubMed ID: 30953339
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of caspases inhibits the release of apoptotic bodies: Bcl-2 inhibits the initiation of formation of apoptotic bodies in chemotherapeutic agent-induced apoptosis.
Zhang J; Reedy MC; Hannun YA; Obeid LM
J Cell Biol; 1999 Apr; 145(1):99-108. PubMed ID: 10189371
[TBL] [Abstract][Full Text] [Related]
55. How cancer cells dictate their microenvironment: present roles of extracellular vesicles.
Naito Y; Yoshioka Y; Yamamoto Y; Ochiya T
Cell Mol Life Sci; 2017 Feb; 74(4):697-713. PubMed ID: 27582126
[TBL] [Abstract][Full Text] [Related]
56. The role of zinc in caspase activation and apoptotic cell death.
Truong-Tran AQ; Carter J; Ruffin RE; Zalewski PD
Biometals; 2001; 14(3-4):315-30. PubMed ID: 11831462
[TBL] [Abstract][Full Text] [Related]
57. Pharmacological caspase inhibitors: research towards therapeutic perspectives.
Kudelova J; Fleischmannova J; Adamova E; Matalova E
J Physiol Pharmacol; 2015 Aug; 66(4):473-82. PubMed ID: 26348072
[TBL] [Abstract][Full Text] [Related]
58. Does "death receptor" signaling play a role in tumorigenesis and cancer therapy?
Villunger A; Strasser A
Oncol Res; 1998; 10(11-12):541-50. PubMed ID: 10367935
[TBL] [Abstract][Full Text] [Related]
59. Induction of apoptosis in MDA-MB-231 human breast carcinoma cells with an ethanol extract of Cyperus rotundus L. by activating caspases.
Park SE; Shin WT; Park C; Hong SH; Kim GY; Kim SO; Ryu CH; Hong SH; Choi YH
Oncol Rep; 2014 Dec; 32(6):2461-70. PubMed ID: 25241797
[TBL] [Abstract][Full Text] [Related]
60. Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio.
Mühlethaler-Mottet A; Flahaut M; Bourloud KB; Auderset K; Meier R; Joseph JM; Gross N
BMC Cancer; 2006 Aug; 6():214. PubMed ID: 16930472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
